- socially bharat
- October 25, 2024
Medivir’s CEO to BioStock: “Fostrox is unique in its kind”
Medivir’s phase I study, which established clinical proof-of-concept for fostrox as monotherapy in patients with liver cancer, has been published in
READ MORE
- socially bharat
- September 12, 2024
Medivir to present mature clinical data for fostrox + Lenvima at ESMO Conference and to host a webcast on September 16
Stockholm — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of